GLP-1RA for prevention of CR outcomes in T2D

Abstract

This meta-analysis of GLP-1RA CVOTs sheds new light on the cardiorenal efficacy of GLP-1RAs in patients with T2D.

Topics: 

Citation
Giugliano D et al. Diabetes Obes Metab 2019;2(11):2576-2580.